Stocks · Health care · Pharmaceutical Preparations

Mineralys Therapeutics, Inc.

MLYS Clue Score35
United States Fiscal year ends December CIK 0001933414 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
30 Mar 2026
Director
Buy indirect
58,300
$24.16
$1.41M
Ra Capital Management, L.p.
27 Mar 2026
Director
Buy indirect
310,700
$23.67
$7.35M

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 58
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 1,088,447
History held since 13 Feb 2023